Viswa completed his PhD in Cellular and Molecular Biology at the University of Wisconsin-Madison, where he studied ways to enhance nucleic acid vaccines as therapies for prostate cancer. Having invented three (patents pending) molecular technologies to improve anti-tumor vaccination, he didn't expect to part ways with the exciting field of tumor immunology until he was wooed by the promise of Recursion's platform. Originally from India, he has a passion for reinventing dishes of his home cuisine and changing the minds of the few Americans who aren't already ardent fans of Indian food. When he isn't working, thinking about work, or cooking, Viswa loves to sate his wanderlust, get lost in a good book, or engage in contemplative philosophical banter about the meaning of everything. And nothing.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.